Key Takeaways
- Summer wiped out, not the franchise: Standalone revenue collapsed to ₹229 crores from ₹373 crores YoY on a rain-shortened summer and a high base, yet it was still the second-best June quarter ever.
- The non-cooler portfolio is now a material, fast-growing hedge: Tower fans, kitchen cooling fans, LSVs and storage water heaters grew robustly even in a dead summer and now make up ~25% of revenue, growing at a 50%+ CAGR.
- International subsidiaries are being radically restructured: Australia turned fully asset-light after a factory exit and a pivot from banned gas heaters to electric, while IMPCO Mexico and Australia are being prepared for a potential sale, with early-stage NDA interest from international buyers.
- Channel inventory overhang will linger: Aggressive pre-season stocking through March, met with subdued summer demand, left channel inventory high, a drag that only clears when tertiary sales restart closer to the next summer.
- What to watch next quarter: Any colour on the monetization process for IMPCO and Australia, the pace of the US retail order finalization, and whether the all-season portfolio sustains its momentum through the monsoon.
The Summer Shock: What Happened and What It Means
- A demand collapse, not a share loss: The summer was the worst in the South and uniformly bad across the rest of India, crushing a category where customers only buy in summer months. Management believes market share may have actually risen because everyone's sales dropped.
- The base-effect trap: Summer '24 delivered far higher growth for air coolers than for air conditioners, so the YoY comp was punishing. Air cooler purchases are also more spontaneous than ACs, making them more exposed to a sudden weather swing.
- Pre-season stocking amplified the pain: Unprecedented record sales in the March '25 quarter pulled demand forward and stuffed the channel, so when summer failed, the inventory overhang was already in place.
- The second-best June ever: Even after the collapse, ₹229 crores of sales surpassed June '22 by 10%, a reminder that the base had been inflated, not that the business structurally shrank.
Achal Bakeri: "The US tariffs are an evolving situation. Every day, it's something different. So we are not holding our breath about what is going to happen."
The Non-Cooler Hedge: All-Season and Counter-Seasonal Products
- Growth when it should not exist: Tower fans, kitchen cooling fans, LSVs and storage water heaters registered very robust growth in a quarter when the core residential cooler portfolio degrew, a performance management called a "saviour."
- Scale and trajectory: These categories together are about 25% of revenue and have delivered a 50%+ CAGR over the last 3-4 years, with management expecting them to keep growing at a faster clip than the overall company.
- Water heater rollout: Introduced last year in a couple of South Indian cities, now expanding to more cities and modern retail stores, with pan-India presence expected a year from now.
- Industrial coolers also grew: Alongside the consumer all-season products, the industrial cooler segment grew impressively, adding another leg to the non-residential story.
- Margin profile is a mixed bag: Some non-air-cooler categories carry higher margins than residential coolers, some lower; LSVs specifically have a "significantly better" margin profile.
Amit Kumar: "So these new categories that we are talking about i.e. the tower fan, the kitchen cooling fan, the LSV also for that matter if I look at last 3 - 4 years, they are clearly giving us a 50%+ kind of CAGR and hence creating a key part of the growth portfolio that we are building."
International Subsidiaries: Restructuring and Potential Monetization
IMPCO Mexico
- Mild summer broke a streak: After three consecutive years of ~30% CAGR, IMPCO was hit by a mild summer, and the EBITDA margin suffered solely from operating leverage.
- IPR transaction concluded: GSK concluded an IPR and technology know-how sale to IMPCO Mexico for USD 5.2 million (~₹44 crores), with the first tranche of ₹22 crores received in the June quarter.
Symphony Australia
- A complete business-model reset: The factory lease expired in July '25 and was not renewed, making the business fully asset-light. Manufacturing is now outsourced to Australia, India and China. The product line pivoted from gas ducted heaters, which were banned in Victoria, to electric products: ducted reverse-cycle AC, electric fireplaces, panel heaters and oil heaters.
- Distribution footprint expanded: Third-party warehouses and salespeople now cover all major Australian cities, whereas previously the business was concentrated in Southern Australia.
- Second straight quarter of YoY growth: Management believes the business is at the bottom of the hockey-stick curve, at the beginning of an up cycle.
Monetization process
- Early-stage interest: International companies have expressed very good interest in IMPCO and Australia, with NDAs being signed. Management will share news when closer to a deal.
- Timeline: A transaction may materialize toward the end of the current financial year or early in the next financial year, though the process is still at a very early stage.
- No further acquisitions: Management categorically ruled out any future international or domestic acquisitions. The export model going forward will resemble the Brazil model: a local team with feet on the ground selling products.
Achal Bakeri: "So what we believe internally is that we are at the bottom of that hockey stick curve. It's taken a long time to get there or to get to the point where you sort of at the beginning of the up cycle of the hockey stick curve, but we believe that's where we are."
Channel Inventory: The Overhang That Will Linger
- How it built up: Inventory was placed very aggressively with the channel through the March '25 quarter, and then subdued summer demand left that inventory sitting at channel endpoints.
- Management's stance: The exact inventory level was not disclosed, with management stating they are not at liberty to put out exact numbers at this stage, while acknowledging that "the inventory is high."
- The clearing mechanism: Normalization only begins when tertiary sales restart, which means closer to the next summer season. There is no consumer sales activity during the monsoon to work down the overhang.
Exports and the US Opportunity
- US sales are growing: US sales this quarter were significantly higher than the same quarter last year and up compared to the last quarter.
- Retail traction: All major US retail chains have shortlisted some Symphony models, samples have reached them, and the company is in the process of finalizing large orders for the upcoming summer.
- Tariff advantage: Tariffs on products from India are lower than tariffs on products from China, Symphony's primary competitor. Management is not losing sleep over tariffs, noting that what matters is the tariff differential when shipping for summer '26 begins.
- Export outlook: Exports, both third-party and through subsidiaries, have done well and are expected to continue doing well, with performance this year likely similar to last year's good showing, if not significantly improved.
- No capacity or investment constraint: The business model does not require much investment to scale exports, and tariffs have not impacted plans in any manner.
BLDC, Product Investment and Capital Allocation
- BLDC with profitability: Unlike other brands where BLDC fans generate top-line growth but register losses, Symphony is growing its BLDC portfolio profitably. BLDC coolers were launched two years ago, and the BLDC tower fan has been in the market for more than a year.
- New product pipeline: The Air Force range of air coolers launched during the quarter received very strong traction, fuelling scale-up and range expansion. Several new models are in the pipeline for this year.
- R&D spend is modest: Investment in R&D and product development will be less than ₹10 crores, with no significant capex required. Management will continue to invest whatever is required to meet market requirements and keep innovating.
- Capital allocation after monetization: The business model is asset-light and capital-light, so proceeds from any IMPCO or Australia monetization will mostly not be needed in the business. Management has no specific thoughts yet on their use.
- GSK China loan: GSK China repaid ~₹28 crores of its inter-company loan to Symphony India, bringing the outstanding down to ~₹26 crores from a peak of ~₹60 crores in May '24. The balance is expected to be fully repaid by year-end, with ~₹22 crores coming mostly in the current quarter from IPR sale proceeds and the remainder from internal accrual.
Nrupesh Shah: "And unlike other brands were in BLDC fan, despite that top line growth, they keep on registering losses, we are having and we are going to grow with profitability."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| GSK China loan repayment | Outstanding ~₹26 crores fully repaid; ~₹22 crores mostly in current quarter from IPR proceeds, remainder from internal accrual | By end of FY26 |
| Channel inventory normalization | High channel inventory clears only when tertiary sales begin | Closer to next summer season |
| Water heater pan-India presence | Gradual rollout from current limited South India presence to pan-India and modern retail | ~1 year from now |
| IMPCO / Australia monetization | Transaction possible; early-stage NDA interest from international buyers | End of FY26 or early FY27 |
| No further acquisitions | Categorical commitment: no international or domestic acquisitions; export model will follow Brazil pattern | Ongoing |
| US retail orders | All major US retail chains have shortlisted models; large orders being finalized for upcoming summer | Ahead of summer '26 |
Key Metrics
| Metric | Q1 FY26 |
|---|---|
| Standalone revenue | ₹229 cr, down from ₹373 cr YoY |
| Standalone PAT | ₹37 cr, down from ₹69 cr YoY |
| Exceptional gain (Pathways recovery) | ~₹5 cr |
| Consolidated revenue (continuing ops) | ₹251 cr |
| Consolidated PAT (continuing ops) | ₹39 cr, PAT margin 15.4% |
| Consolidated revenue (discontinuing ops) | ₹99 cr |
| Consolidated PAT (discontinuing ops) | ₹3 cr, EBITDA margin 12.1% |
| Trailing 12 months revenue | ₹1,038 cr, vs ₹996 cr in prior 12 months |
| Trailing 12 months EBITDA | ₹229 cr, almost flat |
| Trailing 12 months PBT before exceptional item | ₹283 cr, up from ₹275 cr |
| Trailing 12 months ROCE | Infinite; RONW 18% |
| Treasury | ₹363 cr as on June 30, 2025 |
| Interim dividend | ₹1 per share, totalling ~₹7 cr |
| Final dividend | ₹8 per share |
| Last year total payout | 84% of consolidated PAT |
| All-season and counter-seasonal product sales share (trailing 12 months) | ~25% of Symphony India sales, up from less than 10% earlier |
| GSK China IPR transaction to IMPCO Mexico | USD 5.2 mn (~₹44 cr); first tranche ₹22 cr concluded in June 2025 quarter |
| GSK China outstanding loan to Symphony India | ~₹26 cr, down from peak of ~₹60 cr in May 2024 |
| US sales growth | Significantly higher YoY and QoQ |